Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04746924
Title	A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer
Recruitment	Active, not recruiting
Gender	both
Phase	Phase III
Variant Requirements	Yes
Sponsors	BeiGene
Indications	lung non-small cell carcinoma
Therapies	Tislelizumab BGBA1217 + Tislelizumab Pembrolizumab
Age Groups:	senior \| adult
Covered Countries	USA \| NLD \| ITA \| FRA \| ESP \| DEU \| AUS